Amgen (Argentina) Top Management

AMGN Stock  ARS 18,000  50.00  0.28%   
Analysis of Amgen's management performance can provide insight into the company performance.
  
Check out Trending Equities to better understand how to build diversified portfolios, which includes a position in Amgen Inc. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in inflation.
Symbol  AMGN
Name  Amgen Inc
TypeStock
Country  
 Argentina
Exchange  BA

Information on Amgen Inc Leadership is currently not available.

If you believe this information is not accurate please let us know and we will check it out. Check all delisted instruments across multiple markets.

Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.

Thematic Opportunities

Explore Investment Opportunities

Build portfolios using Macroaxis predefined set of investing ideas. Many of Macroaxis investing ideas can easily outperform a given market. Ideas can also be optimized per your risk profile before portfolio origination is invoked.
Investing Ideas  

Amgen Management Team Effectiveness

The company has return on total asset (ROA) of 9.13 % which means that it generated a profit of $9.13 on every $100 spent on assets. This is normal as compared to the sector avarege. Similarly, it shows a return on equity (ROE) of 60.79 %, meaning that it generated $60.79 on every $100 dollars invested by stockholders. Amgen's management efficiency ratios could be used to measure how well Amgen manages its routine affairs as well as how well it operates its assets and liabilities.
Some institutional investors establish a significant position in stocks such as Amgen in order to find ways to drive up its value. Retail investors, on the other hand, need to know that institutional holders can own millions of shares of Amgen, and when they decide to sell, the stock will often sell-off, which may instantly impact shareholders' value. So, traders who get in early or near the beginning of the institutional investor's buying cycle could potentially generate profits.
The company has Profit Margin (PM) of 22.55 %, which can signify that it executes well on its competitive strategies and has good control over its expenditures. This is very large. Similarly, it shows Operating Margin (OM) of 35.76 %, which suggests for every 100 dollars of sales, it generated a net operating income of $35.76.

Amgen Inc Benchmark Summation

Operator
The output start index for this execution was zero with a total number of output elements of sixty-one. Amgen Inc Price Series Summation is a cross summation of Amgen price series and its benchmark/peer.
String symbol = request.getParameter("s");

About Amgen Management Performance

The success or failure of an entity such as Amgen Inc often depends on how effective the management is. Amgen management team is responsible for propelling the future growth in the right direction and administering and controlling the business activities and accounting for the results. Ineffective management usually contributes to failure in the company's future performance for all stakeholders equally, but most importantly, for investors. So it is important to measure the effectiveness of Amgen management before purchasing its stock. In many ways, it's all about finding the answer to one important question - Are they doing the right thing right now? How would we assess whether the Amgen management is utilizing all available resources in the best possible way? Also, how well is the company doing relative to others in its sector and the market as a whole? The answer can be found by analyzing a few important fundamental indicators such as return on assets and return on equity.
Amgen Inc. discovers, develops, manufactures, and delivers human therapeutics worldwide. Amgen Inc. was founded in 1980 and is headquartered in Thousand Oaks, California. AMGEN INC operates under Drug ManufacturersGeneral classification in Argentina and is traded on Buenos-Aires Stock Exchange. It employs 24300 people.
Please note, the presentation of Amgen's financial position, as portrayed in its financial statements, is often influenced by management's estimates, judgments, and sometimes even manipulations. In the best case, Amgen's management is honest, while the outside auditors are strict and uncompromising. Please utilize our Beneish M Score to check the likelihood of Amgen's management manipulating its earnings.

Complementary Tools for Amgen Stock analysis

When running Amgen's price analysis, check to measure Amgen's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Amgen is operating at the current time. Most of Amgen's value examination focuses on studying past and present price action to predict the probability of Amgen's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Amgen's price. Additionally, you may evaluate how the addition of Amgen to your portfolios can decrease your overall portfolio volatility.
Portfolio Volatility
Check portfolio volatility and analyze historical return density to properly model market risk
Stocks Directory
Find actively traded stocks across global markets
AI Portfolio Prophet
Use AI to generate optimal portfolios and find profitable investment opportunities